Lightnews — Scholar-powered news

American Association for Cancer Research (AACR) @theaacr.bsky.social · 10h

Researchers balance treatments to find a safer option for frail patients with multiple myeloma, the FDA approves immunotherapy for some skin cancer patients with a high risk of recurrence, and more from the Week in Cancer News. buff.ly/XZwq8sY

October 10: The Week in Cancer News | Cancer Today

Older people with multiple myeloma can receive a less toxic drug regimen, and the FDA approves an immunotherapy for people with high-risk skin cancer.

www.cancertodaymag.org

2

American Association for Cancer Research (AACR) @theaacr.bsky.social · 1d

Better accommodations for deaf people could help improve communication for all people seeking cancer care. Learn more in the latest issue of Cancer Today buff.ly/19q6P31

1

American Association for Cancer Research (AACR) @theaacr.bsky.social · 1d

The @US_FDA approved the immunotherapy cemiplimab-rwlc for adults with cutaneous squamous cell carcinoma who are at high risk for recurrence after treatment with surgery and radiation therapy: www.fda.gov/drugs/resour...

FDA approves cemiplimab-rwlc

On October 8, 2025, the Food and Drug Administration approved cemiplimab-rwlc (Libtayo, Regeneron Pharmaceuticals Inc.).

www.fda.gov

1 2

American Association for Cancer Research (AACR) @theaacr.bsky.social · 1d

We thank all our Sustaining Members who came together at this year's AACR Industry Roundtable in Philadelphia. Collaboration is critical to making advances against the collection of devastating diseases we call cancer. #CancerResearchSavesLives®

1

American Association for Cancer Research (AACR) @theaacr.bsky.social · 1d

To reach the next generation of cancer researchers, the @AACR offers programs for high school and undergraduate students. Learn about these educational opportunities for aspiring scientists in the latest issue of Leading Discoveries: buff.ly/ffIc89G

1 1

American Association for Cancer Research (AACR) @theaacr.bsky.social · 2d

A series of papers published in the AACR journal Clinical Cancer Research shared key considerations for how to improve dosage optimization in oncology. Learn more on the AACR Blog: buff.ly/ZFH90e3

1 1

American Association for Cancer Research (AACR) @theaacr.bsky.social · 2d

AACR President-Elect Keith T. Flaherty opened the AACR Industry Roundtable. Participants are discussing topics such as creating customized dose optimization strategies, current industry and regulatory insights, and the patient's perspective. #CancerResearchSavesLives®

1

American Association for Cancer Research (AACR) @theaacr.bsky.social · 2d

Author Jonathan Gluck discusses living with multiple myeloma, the importance of advancing research, and finding ways to maximize your well-being. Read more: buff.ly/jGqU9OK @jgluck.bsky.social

3

American Association for Cancer Research (AACR) @theaacr.bsky.social · 2d

Submit an abstract by November 6 for the AACR Special Conference on Innovations in Prostate Cancer Research and Treatment (Jan 20-22; Boston), chaired by Peter S. Nelson, Elena Castro, Patrick G. Pilié, and Eliezer M. Van Allen. Learn more:
buff.ly/MBBHFX7
#AACRprostate26 @vanallenlab.bsky.social

1

American Association for Cancer Research (AACR) @theaacr.bsky.social · 3d

Learn about the oncology approvals issued by the @fda.gov during the third quarter of 2025 on the #AACRBlog: buff.ly/sAdO0nn

3

American Association for Cancer Research (AACR) @theaacr.bsky.social · 3d

Cochair Sheila Stewart adjourned the AACR Grantee Summit 2025: Igniting Innovation in Cancer Research. We thank the summit cochairs, grant funders, AACR leaders, and the AACR grantees for their enthusiastic participation in this outstanding program.
#AACRGrants

7

American Association for Cancer Research (AACR) @theaacr.bsky.social · 3d

AACR Chief Philanthropic Officer Mitch Stoller hosted a fireside chat with AACR Past President Patricia M. LoRusso during the AACR Grantee Summit.
#AACRGrants

4

American Association for Cancer Research (AACR) @theaacr.bsky.social · 3d

Dr. Katerina A. Politi, Scientific Director of the Center for Thoracic Cancers at the Yale Cancer Center, delivered a keynote address to open the second day of the AACR Grantee Summit. #AACRGrants

5

American Association for Cancer Research (AACR) @theaacr.bsky.social · 4d

AACR President Lillian L. Siu opened the AACR Grantee Summit with a keynote address. The summit convenes AACR grantees, funding partners, and special guests to share results and foster collaborations.
#AACRGrants

5

American Association for Cancer Research (AACR) @theaacr.bsky.social · 4d

Cochairs Sheila Stewart and Manuel Hidalgo joined @AACR_CEO Margaret Foti in welcoming attendees to the AACR Grantee Summit. The summit convenes AACR grantees, funding partners, and special guests to share results and foster collaborations.
#AACRGrants @sastewartlab @DrMhidalgo

6

American Association for Cancer Research (AACR) @theaacr.bsky.social · 7d

HPV cancer-causing infections declined after the widespread update of vaccines, radiation can prevent recurrence in locally advanced bladder cancer, and more. Read these stories and more from Cancer Today magazine's Week in Cancer News. www.cancertodaymag.org/cancer-talk/...

1 1 4

American Association for Cancer Research (AACR) @theaacr.bsky.social · 7d

Blood thinners can be an effective way to manage blood clots during cancer treatment, but they come with their own risks. Could using a lower dose prove effective in the long term? Learn more in Cancer Today: www.cancertodaymag.org/fall-2025/a-...

2 3

American Association for Cancer Research (AACR) @theaacr.bsky.social · 9d

"Every moment I had with my mom was worth fighting for." Justin Wineburgh opens up about love, loss, and what cancer caregiving taught him in this moving episode of Believe in Progress. youtu.be/eBSZu8WGIaU&...

3

American Association for Cancer Research (AACR) @theaacr.bsky.social · 10d

Many of Aurora Lucas' posts look like what you expect on social media—dogs, sunsets, selfies—but tune in and you'll learn about scans, side effects, and other challenges she faces as a young adult with lung cancer. www.cancertodaymag.org/fall-2025/fi... #younglungcancer

1 2

American Association for Cancer Research (AACR) @theaacr.bsky.social · 10d

Submit an abstract by October 1 for the AACR Special Conference on Cancer Evolution (December 4-6; Albuquerque), chaired by Mariam Jamal-Hanjani, Kenneth J. Pienta, and Mara H. Sherman and held in association with #AACRCEWG.
buff.ly/meDBvm2
#AACRevol25 @marasherman.bsky.social

2 1

American Association for Cancer Research (AACR) @theaacr.bsky.social · 11d

At a recent workshop cohosted by the AACR and FDA.gov, cancer researchers discussed metrics that could give early insights into a treatment's efficacy. Learn more on the #AACRBlog: buff.ly/v1tMl2I

1 4

American Association for Cancer Research (AACR) @theaacr.bsky.social · 11d

Submit your late-breaking abstract by September 30 for the San Antonio Breast Cancer Symposium (December 9-12). Learn more:
buff.ly/oIS53kD
#SABCS25

2

American Association for Cancer Research (AACR) @theaacr.bsky.social · 14d

A new trial will test the effectiveness of AI in reading mammograms, vitamin B12 has been found to lower the risk of severe hand-foot syndrome during chemotherapy, and more. Read these stories and more from Cancer Today magazine's Week in Cancer News. www.cancertodaymag.org/cancer-talk/...

September 26: The Week in Cancer News | Cancer Today

US trial to look at impact of AI-assisted mammograms, and vitamin B12 may help curb chemotherapy-associated hand-foot syndrome.

www.cancertodaymag.org

2 3

American Association for Cancer Research (AACR) @theaacr.bsky.social · 15d

ER-positive, HER2-negative is the most common subtype of breast cancer. Learn more about prevention, screening, and treatment options for breast: buff.ly/dYFDLF1

Breast Cancer Overview - American Association for Cancer Research (AACR)

More than 250,000 women a year are diagnosed with breast cancer in the U.S. Learn about the prevention, screening, and treatment options for breast cancer.

www.aacr.org

2 2

American Association for Cancer Research (AACR) @theaacr.bsky.social · 15d

The approval for imlunestrant was based on results from the EMBER-3 trial, which were presented at the 2024 San Antonio Breast Cancer Symposium. Learn more about the trial and more research into SERDs and other molecular degraders on the #AACRBlog: buff.ly/VIdnyHX

Please SERD, I Want Some More (Molecular Degraders)

A session on molecular degraders at SABCS 2024 highlighted an exciting new frontier for SERDs, PROTACs, LYTACs, and biparatopic antibodies.

www.aacr.org

1 1 1